| INTRODUCTION
Adenosine deaminase (ADA) is a technically nondemanding, low priced, noninvasive biological marker of high diagnostic value for tuberculous pleurisy, [1] [2] [3] [4] especially when combined with lymphocyte/neutrophil ratio, [5] [6] [7] [8] [9] forasmuch as most of the false-positive findings reported are from empyemas, which are predominantly neutrophilic effusions. 9 ADA provides a reliable basis for treatment decision, particularly in areas where the disease is prevalent, where its sensitivity exceeds 95%. 4 However, it has been supported as a routine screening test in all patients presenting with an exudative pleural effusion (PE) of uncertain origin, regardless of the prevalence of tuberculosis in the population. Furthermore, ADA measurement can be valuable in the diagnosis of patients with lymphocytic PEs not owning to Mycobacterium tuberculosis infection, avoiding inappropriate antituberculous therapy. 4, 5, 9, 10 Specifically, due to its maintained high negative predictive value, irrespective of the rate of prevalence of the disease, a level below 40 U/L virtually excludes tuberculosis 4, 10, 11 as nontuberculous PEs rarely exceed this cutoff set for tuberculous disease. 4, 10 However, the elevation may be limited in early stages of tuberculosis, while high levels of ADA can also be found in patients with lymphomatous, rheumatoid, and sometimes malignant PEs (MPEs). 4, 7, 9 As clinical suspicion is the key to early diagnosis, it has been proposed that, in clinically suspected tuberculosis cases whose initial thoracentesis yields results inconsistent with the suspicion showing a neutrophilic exudate or low ADA levels, 4,5,9,12-16 a follow-up thoracentesis may be helpful for making further clinical decisions. 5, 8, [12] [13] [14] [15] [16] Afterward, most of these atypical tuberculous PEs (TPEs) showed a shift toward mononuclear cell predominance in pleural fluid (PF) 
| MATERIALS AND METHODS

| Subjects and collection of pleural fluids
| Ethical approval
| ADA measurement
Total PF ADA was determined by the Giusti method which is based on the measurement of ammonia released from adenosine when converted to inosine, as described previously. 19 Briefly, after sample collection, PF was centrifuged and the supernatant was incubated in adenosine buffer at 37°C, followed by incubation with Berthelot reagent at 37°C
and subsequent photometric analysis at 405 nm using a Secomam Basic semi-automatic analyzer. Values were standardized against ammonium sulfate solution. Materials were purchased Sigma-Aldrich (Athens, Greece) and Biotechnological Applications Ltd (Athens, Greece).
| Statistical analyses
Data were analyzed using the statistical program IBM SPSS statistical version 22 (SPSS Inc., Chicago, IL, USA). Quantitative variables were presented as mean ± standard deviation (SD), and categorical variables were presented as frequencies with percentages. Chi-square test was used to detect differences between categorical variables.
To identify differences between two independent groups when the dependent variable was either ordinal or continuous, Student's t test or Mann-Whitney U test was used for normally and skewed data, respectively. Differences between more than two unrelated groups were tested by one-way ANOVA. A result was considered statistically significant when the P-value was <.05.
| RESULTS
Demographics, clinical characteristics, and PF ADA variance of the total study group and by gender are presented in Incidentally, in all samples, ADA showed a positive correlation with PF LDH (r = .5, P = .004), not specifically determined for TPEs.
| DISCUSSION
Undoubtedly, a long history of successful use of ADA testing, its simplicity, low cost, and availability of results within few hours make it the preferred option in cases of suspicion of TPE. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] However, there are only few data regarding the variance of sequential ADA measurements that are also limited to specific causes of PEs (TPEs, MPEs, and PPEs). 12 We have established for the first time that, in more than Regarding sequential changes of the PF profiles, there is only one recent study documented interesting results. 12 Firstly, this study reported that ADA levels in TPEs with a lymphocytic shift were significantly higher than those of PPEs with a lymphocytic shift, both in initial and follow-up thoracenteses. 12 Secondly, they found that ADA levels in TPEs which presented initially as lymphocytic exudates with low ADA levels were increased at a subsequent thoracentesis. 12 In our study, none of the PPEs showed a shift to lymphocytic predominance, while there were only two cases of neutrophil-predominant TPEs with conversion to a lymphocytic predominance at follow-up thoracenteses and only one TPE with low ADA value at the initial thoracentesis;
hence, we could not corroborate these results. However, our data are Generally, in current practice, it is proposed that a follow-up thoracentesis may be helpful for making further clinical decisions when initial thoracentesis yields results inconsistent with clinical suspicion of tuberculosis. 4, 5, 9, [12] [13] [14] [15] [16] In particular, it has been reported that ADA activity may be lower at the early stage of tuberculous pleurisy as 10% of TPE patients showed low ADA levels in lymphocytic exudates 8 and the levels may increase long after onset of the disease. 4, 5, 9, [12] [13] [14] [15] [16] A change in neutrophil/lymphocyte ratio or an increase in ADA value may facilitate early diagnosis of TPE 4, 5, 8, 9, [12] [13] [14] [15] [16] ADA alteration seems to be valuable by increasing the index of suspicion for specific pathologies characterized by high ADA levels.
In both TPE and rheumatoid PE cases of our study, biopsy was not performed. Specifically, in the case of rheumatoid PE, the increase in ADA level above the threshold heightened clinical suspicion of an entity characterized by high ADA levels. Nevertheless, it was the positive serology that finally established the diagnosis. Otherwiseif serologic test results were negative-pleural biopsy would be an inevitable step to exclude tuberculosis or malignancy. As far as the aforementioned TPE case is concerned, the increase in ADA value at follow-up thoracentesis confirmed initial clinical suspicion of active tuberculosis.
On the other hand, as the standard ADA test measures enzyme activity, decreased ADA values may potentially be seen during the course of a treatment. 5 According to our results, one-fifth of the PEs had continued downward trend of ADA values. The small size of this group limits the generalizability of this finding which, however, points to the need for further research.
Moreover, an association between age and ADA has been reported previously with much higher levels of PF ADA among younger patients with TPE. [20] [21] [22] [23] [24] We did find significant age-related differences in mean ADA values in neither the entire study nor tuberculous groups. Another study documented that current smoking was a significant predictor of TPE with a low ADA level, as various components of cigarette smoke affect the immune response. 25 We did not identify any correlation be-
tween ADA values and participants' smoking status. 26 However, recently, low levels (<15 U/L) and high levels (>40 U/L) of ADA were associated with poor survival. 27 The same study documented the possibility that ADA could be a surrogate of systemic consequences of the primary cancer and tumor burden in pleural space. 27 Therefore,
increasing ADA values in MPE could be explained by activation of the immune system in the pleural space, leading to the activation of unusual pathways in cancer. 28 Conversely, another study established better radiologic outcomes in patients with MPE who underwent pleurodesis and had pleural ADA lower than 17 U/L. 29 In this study, we measured total ADA activity, including activity of ADA-1 and ADA-2 isoforms. ADA-1 is ubiquitous in all human cells, and ADA-2 is mostly in monocytes which are found to increase significantly in the tuberculosis group. Assumably, discrimination of ADA isoforms could shed more light on the physical processes leading to continually increasing ADA values in MPEs.
In this study, a correlation was observed between PF ADA and LDH values. This finding is consistent with previous research 5, 30 and could be explained according to Lee et al. 5 Specifically, it has been documented that patients who had high ADA levels also had high pleural fluid LDH levels. LDH is associated with cell activity; ADA, on the other hand, reflects cell-mediated immunity, in particular T helper 1 type cells (CD4 + T cells) activity.
28
The main limitations of our study were its retrospective nature and the relatively small sample size of some PE groups. A prospective study with larger sample sizes will help to validate our findings. Furthermore, regarding the appropriate time interval for follow-up thoracenteses, it should be noted that sequential thoracenteses were performed at 24-hour intervals. This period may be too short to assess the changes in the pleural fluid ADA levels in PEs.
In conclusion, the determination of PF ADA levels is a reproducible, low cost, and highly accurate method that facilitates the early diagnosis of tuberculosis. Overall, the detected measurement deviations do not appear to affect the final diagnosis. However, in specific cases, ADA measurements in different time points can be valuable in directing further diagnostic evaluation, such as in cases of suspected TPEs presented as atypical exudates. More investigation is needed to elucidate the possible prognostic significance of the increasing trend of ADA values in MPEs.
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